On January 16, 2026, the U.S. Food and Drug Administration (FDA) released a statement saying they had granted full approval ...
FDA approves KBroVet chewable tablets for managing canine idiopathic epilepsy.
The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Gepotidacin, a new oral antibiotic class, was approved for uncomplicated UTIs, showing noninferiority to nitrofurantoin in phase 3 trials. Semaglutide's indications expanded to include cardiovascular ...
A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. The Christmas Eve regulatory ...
The U.S. FDA approved 27 drugs in December, the highest month of 2025. This compares to 18 approvals in November and brings ...